Back to Search
Start Over
Guidelines of care for the management of basal cell carcinoma
- Source :
- Journal of the American Academy of Dermatology, vol 78, iss 3
- Publication Year :
- 2018
- Publisher :
- eScholarship, University of California, 2018.
-
Abstract
- Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed.
- Subjects :
- Skin Neoplasms
Pyridines
Basal Cell
Dermatologic Surgical Procedures
Clinical Sciences
Antineoplastic Agents
surgery
basal cell carcinoma
Clinical Research
Neoplasms
Humans
metastasis
Anilides
biopsy
curettage
Early Detection of Cancer
radiotherapy
Neoplasm Staging
Cancer
Photosensitizing Agents
Imiquimod
Dermatology & Venereal Diseases
Carcinoma
staging
United States
Work Group
Second Primary
Cutaneous
Photochemotherapy
topical therapy
Invited Reviewers
Administration
Aminoquinolines
surveillance
Neoplasm Grading
phototherapy
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology, vol 78, iss 3
- Accession number :
- edsair.dedup.wf.001..168e9f30d70e169ff7e696e9bcdde472